Financials
- Market Capitalization 480.69 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.94
Relación precio/flujo de caja
100.37
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2946 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 7.94 USD | +2.19% | -16.77% | -2.58% | +103.59% | 482.71 M USD | ||
| 2948 | STTK Shattuck Labs, Inc. - Common Stock | 6.29 USD | -2.18% | -13.24% | +34.69% | +706.41% | 482.32 M USD | ||
| 2953 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.76 USD | +8.53% | +0.91% | +22.59% | -19.17% | 479.19 M USD | ||
| 2965 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.55 USD | -3.73% | -20.10% | -6.63% | -25.48% | 468.19 M USD |